Chahrazad CHERIFI
@chahrazadcheri1
postdoctoral researcher, KU Leuven university
ID: 1204346909789433856
10-12-2019 10:27:51
24 Tweet
37 Followers
96 Following
For all of you who do not give up on developing therapies for osteoarthritis, here is our latest review on the Wnt and TGF-β signalling pathways. A delight to work on this with Chahrazad CHERIFI and Silvia Monteagudo. journals.sagepub.com/doi/full/10.11…
Plus de 233 000 créneaux sont ouverts à la vaccination dans 654 centres sur toute la France. Faites passer le mot, partagez Vite Ma Dose de Vaccin ! autour de vous. L’adresse est simple : vitemadose.covidtracker.fr. On ne vend rien, on n’y gagne rien. À part optimiser la campagne vaccinale.
Our last paper "Hypoxia induces DOT1L in articular cartilage to protect against osteoarthritis" has been highlighted in Nature Reviews Rheumatology! Rik Lories Astrid De Roover Ana Escribano Chahrazad CHERIFI Frederic Cailotto Lies Storms leire casas
🔴 Available post-doc position European Research Council (ERC) about the in vivo evaluation of #polymer-based nanocarriers [2 years, starting Feb 2022]. Looking for applicants w/ strong expertise in #pharmacology and animal experimentation. Apply 👉 euraxess.ec.europa.eu/jobs/722347 Thanks for RT 🙏
📢 Check this interesting highlight NatRevRheumatol of our lastest study on #epigenetics mechanisms and targets in #osteoarthritis ! 👌👌👩🏻🔬 Reem Assi Rik Lories Chahrazad CHERIFI Research done Dept of Development and Regeneration - KU Leuven KU Leuven thanks to FWO